Form 8-K Star Holdings For: May 10
http://archive.fast-edgar.com/20240510/AN2PK22CZ22292Z2222M22YUF2RHZM22B262
Filed on: May 10, 2024
Form 10-Q Protalix BioTherapeutics For: Mar 31
http://archive.fast-edgar.com/20240510/A4ZQ922CZ222KTBZ2B2B2ZZ2EPAQZM2IZ262
Filed on: May 10, 2024
Form D/A Parsifal Fund, LP
http://archive.fast-edgar.com/20240510/AN22C2228222I9Z8222D2ZOETJMKS222Z262
Filed on: May 10, 2024
Form 8-K Douglas Elliman Inc. For: May 09
0001878897false00018788972024-05-092024-05-09UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934Date of Report (Date of earliest event reported): May 9, 2024 DOUGLAS ELLIMAN INC.(Exact Name of Registrant as Specified in Its Charter)Delaware(State or Other Jurisdiction of Incorporation)001-41054 87-2176850(Commission File Number) (I.R.S. Employer Identification... (continue reading...)
Form 8-K Akero Therapeutics, Inc. For: May 10
false 0001744659 0001744659 2024-05-10 2024-05-10
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 10, 2024
Akero Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-38944 81-5266573
(State or other... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K SANUWAVE Health, Inc. For: May 10
-
Form SD BECTON DICKINSON & CO
-
Form D/A Parsifal Master Fund
-
Form 8-K Sylvamo Corp For: May 10
-
Form 8-K Inspired Entertainment, For: May 10
-
Form 8-K Workhorse Group Inc. For: May 10
-
Form 10-Q Star Holdings For: Mar 31
-
Form 13F-HR Banco Santander, S.A. For: Mar 31
-
Form 6-K Crescent Point Energy For: May 10
-
Form 10-Q Luminar Technologies, For: Mar 31
-
Form 10-Q Instil Bio, Inc. For: Mar 31
-
Form 8-K Aeluma, Inc. For: May 10
-
Form 10-Q ANI PHARMACEUTICALS INC For: Mar 31
-
Form 8-K Mondee Holdings, Inc. For: May 10
-
Form D CR-0318 Fund II, a serie
-
Form 13F-NT Grupo Empresarial Santan For: Mar 31
-
Form D/A Dark Forest Global Equit
-
Form 13F-HR Intermede Investment For: Mar 31
-
Form 8-K Humacyte, Inc. For: May 10
-
Form 8-K i3 Verticals, Inc. For: May 10
-
Form 8-K PROKIDNEY CORP. For: May 10
-
Form 8-K TruBridge, Inc. For: May 10
-
Form 424B3 Goodness Growth Holdings
-
Form 10-Q ENBRIDGE INC For: Mar 31
-
Form 6-K Crescent Point Energy For: Mar 31
-
Form 10-Q DigitalOcean Holdings, For: Mar 31
-
Form 424B3 Goodness Growth Holdings
-
Form 8-K Ubiquiti Inc. For: May 10
-
Form D/A Dark Forest Global Equit
-
Form 8-K AMC Networks Inc. For: May 10
-
Form 8-K DigitalOcean Holdings, For: May 10
-
Form S-3/A Clean Energy Technologie
-
Form ARS Goodness Growth Holdings For: Dec 31
-
Form 8-K ENBRIDGE INC For: May 10
-
Form 8-K DNOW Inc. For: May 10
-
Form 13F-HR CCLA Investment Manageme For: Mar 31
-
Form 8-K KIORA PHARMACEUTICALS For: May 10
-
Form 8-K ARS Pharmaceuticals, For: May 10
-
Form DEFA14A Goodness Growth Holdings
-
Form 8-K Instil Bio, Inc. For: May 10
-
Form 6-K Telesat Corp For: May 10
-
Form 8-K DANA INC For: May 10
-
Form 10-Q KIORA PHARMACEUTICALS For: Mar 31
-
Form 424B5 Workhorse Group Inc.
-
Form 8-K EQUITY BANCSHARES INC For: May 10
-
Form 6-K Telesat Corp For: May 10
-
Form DEF 14A Goodness Growth Holdings For: Jun 21
-
Form 8-K Protalix BioTherapeutics For: May 10
-
Form S-8 KIORA PHARMACEUTICALS
-
Form 6-K INDIVIOR PLC For: May 10